Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-IGFBP2 Recombinant Antibody (1.A.16) (CBMAB-I0090-YY)

Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
1.A.16
Antibody Isotype
IgM
Application
ELISA, WB

Basic Information

Specificity
Human
Antibody Isotype
IgM
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
0.1M Tris HCl, pH 7.5
Concentration
0.1 mg/ml
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Insulin Like Growth Factor Binding Protein 2
Introduction
The protein encoded by this gene is one of six similar proteins that bind insulin-like growth factors I and II (IGF-I and IGF-II). The encoded protein can be secreted into the bloodstream, where it binds IGF-I and IGF-II with high affinity, or it can remain intracellular, interacting with many different ligands. High expression levels of this protein promote the growth of several types of tumors and may be predictive of the chances of recovery of the patient. Several transcript variants, one encoding a secreted isoform and the others encoding nonsecreted isoforms, have been found for this gene.
Entrez Gene ID
UniProt ID
Alternative Names
Insulin Like Growth Factor Binding Protein 2
Function
Inhibits IGF-mediated growth and developmental rates. IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors.
Biological Process
Aging Source: Ensembl
Cellular response to hormone stimulus Source: Ensembl
Female pregnancy Source: Ensembl
Negative regulation of canonical Wnt signaling pathway Source: ParkinsonsUK-UCL
Positive regulation of activated T cell proliferation Source: BHF-UCL
Regulation of growth Source: UniProtKB-KW
Regulation of insulin-like growth factor receptor signaling pathway Source: UniProtKB
Response to estradiol Source: Ensembl
Response to estrogen Source: Ensembl
Response to glucocorticoid Source: Ensembl
Response to lithium ion Source: Ensembl
Response to mechanical stimulus Source: Ensembl
Response to nutrient Source: Ensembl
Response to retinoic acid Source: Ensembl
Response to xenobiotic stimulus Source: Ensembl
Signal transduction Source: Ensembl
Cellular Location
Secreted
PTM
O-glycosylated.
More Infomation

Zhang, B., Hong, C. Q., Luo, Y. H., Wei, L. F., Luo, Y., Peng, Y. H., & Xu, Y. W. (2022). Prognostic value of IGFBP2 in various cancers: a systematic review and meta‐analysis. Cancer Medicine, 11(16), 3035-3047.

Sun, L., Zhang, X., Song, Q., Liu, L., Forbes, E., Tian, W., ... & Zhang, W. (2021). IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. Cancer letters, 500, 132-146.

Wei, L. F., Weng, X. F., Huang, X. C., Peng, Y. H., Guo, H. P., & Xu, Y. W. (2021). IGFBP2 in cancer: Pathological role and clinical significance. Oncology Reports, 45(2), 427-438.

Masuo, K., Chen, R., Yogo, A., Sugiyama, A., Fukuda, A., Masui, T., ... & Takaishi, S. (2021). SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. Cancer Science, 112(12), 4987-4999.

Li, T., Forbes, M. E., Fuller, G. N., Li, J., Yang, X., & Zhang, W. (2020). IGFBP2: integrative hub of developmental and oncogenic signaling network. Oncogene, 39(11), 2243-2257.

Fahlbusch, P., Knebel, B., Hörbelt, T., Barbosa, D. M., Nikolic, A., Jacob, S., ... & Kotzka, J. (2020). Physiological disturbance in fatty liver energy metabolism converges on IGFBP2 abundance and regulation in mice and men. International journal of molecular sciences, 21(11), 4144.

Li, T., Zhang, C., Zhao, G., Zhang, X., Hao, M., Hassan, S., ... & Yang, J. (2020). IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer letters, 477, 19-30.

Liu, Y., Li, F., Yang, Y. T., Xu, X. D., Chen, J. S., Chen, T. L., ... & Ke, Y. Q. (2019). IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma. Oncogene, 38(11), 1815-1831.

Khan, S., Lu, X., Huang, Q., Tang, J., Weng, J., Yang, Z., ... & Chen, X. (2019). IGFBP2 plays an essential role in cognitive development during early life. Advanced Science, 6(23), 1901152.

Cai, J., Chen, Q., Cui, Y., Dong, J., Chen, M., Wu, P., & Jiang, C. (2018). Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples. Oncoimmunology, 7(5), e1426516.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-IGFBP2 Recombinant Antibody (1.A.16)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Online Inquiry